Loading clinical trials...
Loading clinical trials...
This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg., pegloticase). Failed ur...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Arthrosi Therapeutics
NCT07089888 · Tophaceous Gout
NCT07453004 · Acute Gouty Arthritis
NCT07504146 · CPPD - Calcium Pyrophosphate Deposition Disease, Gout
NCT07089875 · Gout
NCT06310967 · Hyperuricemia, Hypouricemia, Renal
Arthrosi Investigative Site (105)
Margate, Florida
Arthrosi Investigative Site (102)
Miami, Florida
Arthrosi Investigative Site (109)
Tampa, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions